Investors Land MRTX Even Lower Than Its Secondary Stock Offering
January 13, 2020 at 10:00 AM EST
Looking back to 4 days ago, Mirati Therapeutics Inc (MRTX) priced a 3,076,924 share secondary stock offering at $97.50 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..